Operating Profit Margin
since 2005
Calculation
Gilead Sciences Inc., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Income (loss) from operations1 | ÷ | Product sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 28.24% | = | 100 | × | 7,605) | ÷ | 26,934) |
| Dec 31, 2022 | 27.17% | = | 100 | × | 7,330) | ÷ | 26,982) |
| Dec 31, 2021 | 36.72% | = | 100 | × | 9,918) | ÷ | 27,008) |
| Dec 31, 2020 | 16.72% | = | 100 | × | 4,071) | ÷ | 24,355) |
| Dec 31, 2019 | 19.38% | = | 100 | × | 4,287) | ÷ | 22,119) |
| Dec 31, 2018 | 37.83% | = | 100 | × | 8,200) | ÷ | 21,677) |
| Dec 31, 2017 | 55.04% | = | 100 | × | 14,124) | ÷ | 25,662) |
| Dec 31, 2016 | 58.87% | = | 100 | × | 17,633) | ÷ | 29,953) |
| Dec 31, 2015 | 69.03% | = | 100 | × | 22,193) | ÷ | 32,151) |
| Dec 31, 2014 | 62.37% | = | 100 | × | 15,265) | ÷ | 24,474) |
| Dec 31, 2013 | 41.87% | = | 100 | × | 4,524) | ÷ | 10,804) |
| Dec 31, 2012 | 42.67% | = | 100 | × | 4,010) | ÷ | 9,398) |
| Dec 31, 2011 | 46.77% | = | 100 | × | 3,790) | ÷ | 8,102) |
| Dec 31, 2010 | 53.62% | = | 100 | × | 3,962) | ÷ | 7,390) |
| Dec 31, 2009 | 54.55% | = | 100 | × | 3,529) | ÷ | 6,469) |
| Dec 31, 2008 | 52.68% | = | 100 | × | 2,679) | ÷ | 5,085) |
| Dec 31, 2007 | 57.98% | = | 100 | × | 2,165) | ÷ | 3,733) |
| Dec 31, 2006 | -29.32% | = | 100 | × | (759) | ÷ | 2,588) |
| Dec 31, 2005 | 61.41% | = | 100 | × | 1,111) | ÷ | 1,809) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
Comparison to Competitors
Gilead Sciences Inc., operating profit margin, long-term trends, comparison to competitors
| Gilead Sciences Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Moderna Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 28.24% | 23.49% | 29.35% | 21.77% | -63.54% | 30.85% | 16.00% |
| Dec 31, 2022 | 27.17% | 31.21% | 38.57% | 27.61% | 51.10% | 38.93% | 18.69% |
| Dec 31, 2021 | 36.72% | 31.89% | 31.44% | 25.35% | 75.22% | 55.67% | 25.57% |
| Dec 31, 2020 | 16.72% | 24.81% | 37.70% | 18.99% | -381.82% | 42.09% | 24.19% |
| Dec 31, 2019 | 19.38% | 39.03% | 43.57% | 18.25% | — | 28.10% | 17.99% |
| Dec 31, 2018 | 37.83% | 19.49% | 45.55% | 17.11% | — | 37.77% | 15.53% |
| Dec 31, 2017 | 55.04% | 33.99% | 45.76% | 16.48% | — | 35.41% | 14.19% |
| Dec 31, 2016 | 58.87% | 36.60% | 44.74% | 16.29% | — | 27.38% | 13.40% |
| Dec 31, 2015 | 69.03% | 32.97% | 40.44% | 16.87% | — | 30.51% | 13.77% |
| Dec 31, 2014 | 62.37% | 17.09% | 32.03% | 17.23% | — | 29.74% | 14.82% |
| Dec 31, 2013 | 41.87% | 30.14% | 32.25% | 17.13% | — | 36.11% | 12.30% |
| Dec 31, 2012 | 42.67% | 31.65% | 33.52% | 17.33% | — | 33.20% | 11.85% |
| Dec 31, 2011 | 46.77% | — | 28.19% | 16.27% | — | -46.02% | 10.62% |
| Dec 31, 2010 | 53.62% | — | 37.82% | 16.41% | — | -21.23% | 11.72% |
| Dec 31, 2009 | 54.55% | — | 38.37% | 13.79% | — | -19.54% | 10.38% |
| Dec 31, 2008 | 52.68% | — | 35.50% | 14.72% | — | -37.67% | 11.71% |
| Dec 31, 2007 | 57.98% | — | 27.81% | 15.79% | — | -91.55% | 10.00% |
| Dec 31, 2006 | -29.32% | — | 27.71% | 15.82% | — | -169.68% | 6.38% |
| Dec 31, 2005 | 61.41% | — | 40.33% | 15.84% | — | -187.97% | 10.01% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).